Evidence map›Paper›PMID 34208031›Full record

ReviewGenes2021

Emerging Role of microRNAs and Long Non-Coding RNAs in Sjögren's Syndrome.

Giada De Benedittis, Cinzia Ciccacci, Andrea Latini, Lucia Novelli, Giuseppe Novelli, Paola Borgiani

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Advances in Pathogenesis of Sjögren's Syndrome.Journal of immunology research · 2021
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Sjögren syndrome: looking forward to the future.Therapeutic advances in musculoskeletal disease · 2022
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Giada De BenedittisDepartment of Biomedicine & Prevention, Genetics Section, University of Rome Tor Vergata, 00133 Rome, Italy.
Cinzia CiccacciUniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy.ORCID 0000-0002-3995-7032
Andrea LatiniDepartment of Biomedicine & Prevention, Genetics Section, University of Rome Tor Vergata, 00133 Rome, Italy.
Lucia NovelliUniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy.ORCID 0000-0002-9639-0909
Giuseppe NovelliDepartment of Biomedicine & Prevention, Genetics Section, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-7781-602X
Paola BorgianiDepartment of Biomedicine & Prevention, Genetics Section, University of Rome Tor Vergata, 00133 Rome, Italy.
University of Rome Tor Vergata · ITSaint Camillus International University of Health and Medical Sciences · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sjögren's Syndrome (SS) is a chronic autoimmune inflammatory disease. It is considered a multifactorial pathology, in which underlying genetic predisposition, epigenetic mechanisms and environmental factors contribute to development. The epigenetic regulations represent a link between genetic predisposition and environmental factors. Recent studies suggested a regulatory role for non-coding RNAs in critical biological and disease processes. Among non-coding RNAs, microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) play a critical role in the post-transcriptional mRNA expression, forming a complex network of gene expression regulation. This review aims to give an overview of the latest studies that have investigated the role of miRNAs and lncRNAs in the SS. We included papers that investigated the expression of non-coding RNAs on different tissues, in particular on peripheral blood mononuclear cells and salivary glands. However, regarding the involvement of non-coding RNAs genetic variability in SS susceptibility very few data are available. Further research could help to elucidate underlying pathogenic processes of SS and provide new opportunities for the development of targeted therapies.

Indexed as

AnimalsHumansMicroRNAsRNA, Long NoncodingSjogren's SyndromeMicroRNAsRNA, Long Noncodinglong non-coding RNAsmicroRNAsSjögren’s Syndrome

Identifiers

PMID34208031
PMCPMC8230573
OpenAlexW3167075090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.